Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized study of nab-paclitaxel versus paclitaxel in metastatic HER2-negative breast cancer
2012-002361-36Phase 2Completed
- Sponsor
- OncoSur
- Start
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of paclitaxel in breast cancer (2 arms), sponsored by OncoSur. Primary endpoint: Total Neuropathy Score. Started Jul 2012; status: completed.
02
Drugs
paclitaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2012-002361-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002361-36.